Found: 220
Select item for more details and to access through your institution.
Novel hematological parameters for the evaluation of patients with myeloproliferative neoplasms: the immature platelet and reticulocyte fractions.
- Published in:
- 2017
- By:
- Publication type:
- journal article
2121. Isavuconazole (ISAV) as Primary Anti-Fungal Prophylaxis (PAP) in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS): An Open-Label, Prospective Study.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S718, doi. 10.1093/ofid/ofz360.1801
- By:
- Publication type:
- Article
The addition of all-trans retinoic acid to chemotherapy may not improve the outcome of patient with NPM1 mutated acute myeloid leukemia.
- Published in:
- Frontiers in Oncology, 2013, v. 3, p. 1, doi. 10.3389/fonc.2013.00218
- By:
- Publication type:
- Article
Addition of All-Trans Retinoic Acid to the combination of Fludarabine, Cytarabine, Idarubicin, with or without GCSF in Older Patients with AML Does Not Improve The Outcome in Those with NPM1 Mutations The addition of All-Trans Retinoic Acid to Chemotherpay may not Improve The Outcome of Patient with NPM1 Mutated Acute Myeloid Leukemia
- Published in:
- Frontiers in Oncology, 2013, v. 3, p. 1, doi. 10.3389/fonc.2013.00218
- By:
- Publication type:
- Article
Cytogenetic abnormalities in essential thrombocythemia at presentation and transformation.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single-institution experience.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Clinical Outcomes and Co-Occurring Mutations in Patients with RUNX1-Mutated Acute Myeloid Leukemia.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 8, p. 1618, doi. 10.3390/ijms18081618
- By:
- Publication type:
- Article
Phenotypic subtypes of leukaemic transformation in chronic myelomonocytic leukaemia.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 4, p. 581, doi. 10.1111/bjh.19060
- By:
- Publication type:
- Article
Phase II study of azacitidine with pembrolizumab in patients with intermediate‐1 or higher‐risk myelodysplastic syndrome.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 378, doi. 10.1111/bjh.17689
- By:
- Publication type:
- Article
Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1‐mutated acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 1054, doi. 10.1111/bjh.17347
- By:
- Publication type:
- Article
Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 4, p. 538, doi. 10.1111/bjh.15960
- By:
- Publication type:
- Article
Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 5, p. 760, doi. 10.1111/bjh.14129
- By:
- Publication type:
- Article
Analysis of 2013 European LeukaemiaNet ( ELN) responses in chronic phase CML across four frontline TKI modalities and impact on clinical outcomes.
- Published in:
- British Journal of Haematology, 2016, v. 173, n. 1, p. 114, doi. 10.1111/bjh.13936
- By:
- Publication type:
- Article
Prognostic significance of the Medical Research Council cytogenetic classification compared with the European LeukaemiaNet risk classification system in acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 4, p. 590, doi. 10.1111/bjh.13319
- By:
- Publication type:
- Article
RUNX3 promoter hypermethylation is frequent in leukaemia cell lines and associated with acute myeloid leukaemia inv(16) subtype.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 3, p. 344, doi. 10.1111/bjh.13299
- By:
- Publication type:
- Article
Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis.
- Published in:
- British Journal of Haematology, 2015, v. 168, n. 5, p. 646, doi. 10.1111/bjh.13189
- By:
- Publication type:
- Article
Safety and clinical activity of 5-aza-2′-deoxycytidine (decitabine) with or without Hyper- CVAD in relapsed/refractory acute lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 3, p. 356, doi. 10.1111/bjh.13050
- By:
- Publication type:
- Article
A model for prediction of FLT3- ITD and NPM1 (without FLT3- ITD) positivity in patients with newly diagnosed acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 1, p. 130, doi. 10.1111/bjh.12450
- By:
- Publication type:
- Article
Salvage therapy using FLT3 inhibitors may improve long-term outcome of relapsed or refractory AML in patients with FLT3- ITD.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 5, p. 659, doi. 10.1111/bjh.12299
- By:
- Publication type:
- Article
Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implications.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 7, p. 1434, doi. 10.1002/ajh.27333
- By:
- Publication type:
- Article
Performance of IPSS‐M in patients with myelodysplastic syndrome after hypomethylating agent failure.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. E281, doi. 10.1002/ajh.27043
- By:
- Publication type:
- Article
Evolving trends and outcomes in older patients with acute myeloid leukemia including allogeneic stem cell transplantation.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 9, p. 1383, doi. 10.1002/ajh.26997
- By:
- Publication type:
- Article
Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 4, p. E91, doi. 10.1002/ajh.26858
- By:
- Publication type:
- Article
The outcomes of patients with chronic myeloid leukemia treated with third‐line BCR::ABL1 tyrosine kinase inhibitors.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 4, p. 658, doi. 10.1002/ajh.26852
- By:
- Publication type:
- Article
Implications of RAS mutational status in subsets of patients with newly diagnosed acute myeloid leukemia across therapy subtypes.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 12, p. 1599, doi. 10.1002/ajh.26731
- By:
- Publication type:
- Article
Retrospective comparison of survival and responses to Fludarabine, Cytarabine, GCSF (FLAG) in combination with gemtuzumab ozogamicin (GO) or Idarubicin (IDA) in patients with newly diagnosed core binding factor (CBF) acute myelogenous leukemia: MD Anderson experience in 174 patients
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1427, doi. 10.1002/ajh.26700
- By:
- Publication type:
- Article
Contemporary outcomes in IDH‐mutated acute myeloid leukemia: The impact of co‐occurring NPM1 mutations and venetoclax‐based treatment.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1443, doi. 10.1002/ajh.26694
- By:
- Publication type:
- Article
Low‐dose dasatinib 50 mg/day versus standard‐dose dasatinib 100 mg/day as frontline therapy in chronic myeloid leukemia in chronic phase: A propensity score analysis.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1413, doi. 10.1002/ajh.26689
- By:
- Publication type:
- Article
Urgent cytoreduction for newly diagnosed acute myeloid leukemia patients allows acquisition of pretreatment genomic data and enrollment on investigational clinical trials.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. 885, doi. 10.1002/ajh.26572
- By:
- Publication type:
- Article
Improved outcomes among newly diagnosed patients with FMS‐like tyrosine kinase 3 internal tandem duplication mutated acute myeloid leukemia treated with contemporary therapy: Revisiting the European LeukemiaNet adverse risk classification.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 329, doi. 10.1002/ajh.26451
- By:
- Publication type:
- Article
Dr. Elihu H. Estey (1946–2021).
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 2, p. 166, doi. 10.1002/ajh.26415
- By:
- Publication type:
- Article
Prediction of early (4‐week) mortality in acute myeloid leukemia with intensive chemotherapy.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 1, p. 68, doi. 10.1002/ajh.26395
- By:
- Publication type:
- Article
FLT3 inhibitor based induction and allogeneic stem cell transplant in complete remission 1 improve outcomes in patients with newly diagnosed Acute Myeloid Leukemia with very low FLT3 allelic burden.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. E275, doi. 10.1002/ajh.26202
- By:
- Publication type:
- Article
Long‐term results of low‐intensity chemotherapy with clofarabine or cladribine combined with low‐dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. 914, doi. 10.1002/ajh.26206
- By:
- Publication type:
- Article
Clinical, genomic, and transcriptomic differences between myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN‐RS‐T) and myelodysplastic syndrome with ring sideroblasts (MDS‐RS).
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. E246, doi. 10.1002/ajh.26182
- By:
- Publication type:
- Article
GATA3 rs3824662A allele in B‐cell acute lymphoblastic leukemia in adults, adolescents and young adults: association with CRLF2 rearrangement and poor prognosis.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 3, p. E71, doi. 10.1002/ajh.26065
- By:
- Publication type:
- Article
Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment‐related mortality.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 3, p. 282, doi. 10.1002/ajh.26061
- By:
- Publication type:
- Article
The LEukemia Artificial Intelligence Program (LEAP) in chronic myeloid leukemia in chronic phase: A model to improve patient outcomes.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 2, p. 241, doi. 10.1002/ajh.26047
- By:
- Publication type:
- Article
Overexpression of miR-125a in Myelodysplastic Syndrome CD34<sup>+</sup> Cells Modulates NF-κB Activation and Enhances Erythroid Differentiation Arrest.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0093404
- By:
- Publication type:
- Article
Overexpression of the Toll-Like Receptor (TLR) Signaling Adaptor MYD88, but Lack of Genetic Mutation, in Myelodysplastic Syndromes.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0071120
- By:
- Publication type:
- Article
Ruxolitinib therapy is associated with improved renal function in patients with primary myelofibrosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Patient characteristics and outcomes in adolescents and young adults with classical Philadelphia chromosome-negative myeloproliferative neoplasms.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Comprehensive immunophenotypic study of acute myeloid leukemia with KMT2A (MLL) rearrangement in adults: A single‐institution experience.
- Published in:
- Cytometry. Part B, 2022, v. 102, n. 2, p. 123, doi. 10.1002/cyto.b.22051
- By:
- Publication type:
- Article
Long-term follow-up of patients with newly diagnosed acute myeloid leukemia treated at the University of Texas M. D. Anderson Cancer Center.
- Published in:
- Cancer (0008543X), 1997, v. 80, n. S11, p. 2176, doi. 10.1002/(SICI)1097-0142(19971201)80:11+<2176::AID-CNCR2>3.0.CO;2-G
- By:
- Publication type:
- Article
Myeloid markers in adult acute lymphocytic leukemia. Correlations with patient and disease characteristics and with prognosis.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Granulocyte colony-stimulating factor supportive treatment following intensive chemotherapy in acute lymphocytic leukemia in first remission.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasms.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 5, p. 1, doi. 10.1002/cam4.7093
- By:
- Publication type:
- Article
Heterogenous lung inflammation CT patterns distinguish pneumonia and immune checkpoint inhibitor pneumonitis and complement blood biomarkers in acute myeloid leukemia: proof of concept.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1249511
- By:
- Publication type:
- Article
Outcomes of patients with myelodysplatic syndrome and chronic myelomonocytic leukemia post clofarabine failure.
- Published in:
- Therapeutic Advances in Hematology, 2014, v. 5, n. 2, p. 29, doi. 10.1177/2040620713519742
- By:
- Publication type:
- Article
A prognostic model of therapy-related myelodysplastic syndrome for predicting survival and transformation to acute myeloid leukemia.
- Published in:
- 2014
- By:
- Publication type:
- journal article